Overview Request Sample Pages Request Customization Download PDF
You are viewing: North America Digital Pathology Market analysis
Part of: Digital Pathology Market (Global)

The North America Digital Pathology Market was valued at $280 Million in 2026 and projected to reach to $463.9 Million by 2031, representing a compound annual growth rate of 10.6%. North America's digital pathology market is poised for sustained expansion, supported by increasing adoption of whole slide imaging technology and AI-driven diagnostic tools in major academic medical centers and commercial laboratories.

North America Digital Pathology Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Digital Pathology Market Trends and Insights

  • This 10.6% compound annual growth rate reflects North America's leadership in healthcare digitalization and adoption of advanced diagnostic technologies.
  • North America benefits from strong regulatory frameworks, high healthcare spending, and widespread integration of artificial intelligence in pathology workflows. The North America market is driven by increasing demand for remote diagnostics, laboratory automation, and improved diagnostic accuracy across the region.
  • North America's healthcare institutions are investing heavily in digital infrastructure to enhance operational efficiency and reduce turnaround times for pathology reports.
  • The region's mature healthcare ecosystem and favorable reimbursement policies position North America as a key growth engine for digital pathology innovation through 2031..

Key Market Statistics

  • CAGR (2026-2031) 10.6% CAGR
  • Market Size, 2026 ~USD 280 Million
  • Forecast, 2031 ~USD 463.9 Million
  • Geography North America

North America Digital Pathology Market Overview

Market Leadership Position :

North America commands a dominant share of the global digital pathology market, driven by early adoption of AI-powered diagnostic solutions and substantial investments in healthcare infrastructure modernization across the US and Canada.

Strong Regulatory Environment :

FDA approval pathways and Health Canada regulations provide clear frameworks for digital pathology solutions, accelerating market entry and fostering innovation among North American vendors and healthcare institutions.

High Healthcare Expenditure :

North America's elevated healthcare spending per capita enables widespread adoption of premium digital pathology platforms, with hospitals and diagnostic labs prioritizing advanced imaging and AI integration for improved patient outcomes.

Robust Growth Trajectory :

The region's 10.6% CAGR from 2026 to 2031 reflects sustained demand for remote diagnostics, pathology automation, and integrated laboratory information systems across major US medical centers and Canadian healthcare networks.

North America Digital Pathology Market Dynamics

  • The region's mature healthcare infrastructure, combined with favorable reimbursement policies and strong vendor competition, creates an ideal environment for innovation and market penetration.
  • Healthcare providers are increasingly investing in digital transformation to enhance diagnostic accuracy, reduce turnaround times, and enable remote consultation capabilities. Looking ahead to 2031, North America will continue to lead global digital pathology adoption, driven by regulatory clarity, substantial R&D investments, and growing integration with electronic health records systems.
  • The convergence of cloud-based pathology platforms, machine learning algorithms, and telepathology solutions will further accelerate market growth.
  • Additionally, rising demand for personalized medicine and precision diagnostics will propel healthcare organizations to modernize their pathology workflows, ensuring North America maintains its competitive advantage in the global digital pathology landscape..

Related Ecosystem

Healthcare Analytics

Top Technologies
    Top Companies

      Healthcare It

      Top Technologies
        Top Companies

          Key Takeaways

          • North America's digital pathology market will grow from $280.0M (2026) to $463.9M (2031) at a 10.6% CAGR.
          • North America leads in AI-integrated pathology solutions and remote diagnostic capabilities.
          • North America's strong regulatory environment and reimbursement policies accelerate market adoption.
          • North America's healthcare institutions prioritize laboratory automation and operational efficiency improvements.

          Digital Pathology Market Report Scope

          Report Metric Details
          Base Year 2026
          Fastest Growing Segment PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User)
          Forecast Period 2026–2031
          Growth Rate CAGR of 12.5% from 2026 to 2031
          Largest Segment ONCOLOGY (Therapeutic Area)
          Market Size Base Year (Billions) ~USD 1.59 (2026)
          Revenue Forecast (Billions) ~USD 2.86 (2031)
          Segments Covered Product, Type, Technology, Application, Therapeutic Area, End User

          North America Digital Pathology Market Report Segmentation

          6 segment dimensions are covered across the global market.

          By Product

          • Hardware
          • Software
          • Storage Systems

          By Type

          • AI & Computational Pathology Software
          • Biomarker Discovery & Validation
          • Brightfield Scanners
          • Cloud Storage
          • Drug Discovery & Efficacy Studies
          • Enterprise Digital Pathology Solutions/Platforms
          • Fluorescence Scanners
          • Human Pathology
          • Hybrid Storage
          • Image Analysis Software
          • Image Management Software
          • On-Premise Storage
          • Other Pre-Clinical Research
          • Other Scanners
          • Peripherals & Accessories
          • Toxicology & Safety Assessment
          • Veterinary Pathology
          • Whole Slide Imaging Scanners
          • Workstations & Viewing Systems

          By Technology

          • AI-Enabled Digital Pathology
          • Conventional Digital Pathology

          By Application

          • Academic & Translational Research
          • Clinical Diagnostics
          • Clinical Trials
          • Education & Training
          • Other Applications
          • Pre-Clinical Research
          • Telepathology

          By Therapeutic Area

          • Gastrointestinal Disease
          • Hematology
          • Infectious Disease
          • Neurology
          • Oncology
          • Other Therapeutic Areas

          By End User

          • Academic & Research Institutes
          • Contract Research Organizations
          • Diagnostic & Reference Laboratories
          • Hospitals & Health Systems
          • Other End Users
          • Pharmaceutical & Biotechnology Companies
          • Veterinary Laboratories

          Target Audience

          • Digital Pathology Vendors : Solution providers need North America-specific market data to benchmark competitive positioning, identify growth opportunities, and tailor product offerings to meet regulatory requirements and healthcare provider demands.
          • Healthcare Providers & Hospitals : Hospital networks and diagnostic labs require market intelligence to evaluate digital pathology investments, understand adoption benchmarks, and make informed procurement decisions aligned with industry trends.
          • Investment & Private Equity Firms : Investors seeking North America healthcare technology opportunities need detailed market sizing, growth projections, and competitive analysis to identify acquisition targets and fund allocation strategies.
          • Medical Device Manufacturers : Equipment and imaging device manufacturers require North America market insights to develop complementary digital pathology solutions and establish distribution partnerships with healthcare institutions.
          • Healthcare Consultants & Analysts : Consulting firms and research analysts need comprehensive North America data to support client advisory services, market assessments, and strategic planning for healthcare digitalization initiatives.

          Key Companies in the North America Digital Pathology Market

          CompanyHQOwnershipStrongest segments
          NIKON CORPORATIONJapanPublic CompanyImaging Business (digital cameras and cinema cameras),Precision Equipment Business (FPD exposure equipment),Healthcare Business (life science solutions),
          PIXCELLDATAIsraelPrivate CompanyCore data/analytics platform subscriptions,Professional services & implementation,Value-added modules & advanced analytics,
          SUNQUEST INFORMATION SYSTEMSUnited StatesPrivate CompanyCore LIS (Sunquest Laboratory, Multi-Lab Networking, Collect),Pathology and Anatomic Pathology (PowerPath, CoPathPlus),Blood Bank and Transfusion Management,
          CERNER CORPORATIONUnited StatesPrivate CompanyCerner Millennium and core clinical/financial applications,HealtheIntent population health and data platform,CareAware and device connectivity solutions,
          ZENSAR TECHNOLOGIES LTDIndiaPublic CompanyDigital and Application Services,Cloud Infrastructure and Security,Experience, Brand, and Creative Services,
          DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing, single-use, cell culture, filtration),Life Sciences (genomics, mass spec, imaging, lab automation),Diagnostics (clinical instruments, consumables, software),
          KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health,
          SECTRA ABSwedenPublic CompanyImaging IT Solutions,Secure Communications,Business Innovation (orthopedics, education, precision diagnostics),
          HAMAMATSU PHOTONICS K.K.JapanPublic CompanyElectron Tube (incl. photomultiplier tubes and radiation/x-ray sensors),Opto-Semiconductor (photodiodes, APDs, SPADs, MPPC, UV/IR sensors),Imaging and Measurement Instruments (cameras, spectrometers, x-ray systems, software),
          QUANTERIX CORPORATIONUnited StatesPublic CompanyHD-X instrument and related assays/consumables,SR-X instrument and related assays/consumables,SP-X planar array platform and multiplex assays,
          FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics),Business Innovation (office, document solutions, graphic communications),Electronics (display, semiconductor materials, storage, industrial equipment),
          HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Aptima, Panther, ThinPrep, Rapid Fetal Fibronectin),Breast Health (3D mammography, biopsy, localization, treatment support),GYN Surgical (MyoSure, NovaSure, Fluent, Acessa, CoolSeal),
          AIFORIAFinlandPublic CompanyClinical AI suite (viewer + cancer diagnostics),Aiforia Create (AI model development platform),Services, customization, and other software,

          NIKON CORPORATION

          Nikon Corporation is a Japanese public company founded in 1917 with 19,928 employees, known for manufacturing imaging and optical products.

          PIXCELLDATA

          Pixcelldata is a private company founded in 2010 and based in Israel.

          SUNQUEST INFORMATION SYSTEMS

          Sunquest Information Systems is a private company founded in 1979 and based in the United States.

          CERNER CORPORATION

          Cerner Corporation is a private company founded in 1979 in the United States with 25,150 employees, specializing in healthcare information technology.

          ZENSAR TECHNOLOGIES LTD

          Zensar Technologies Ltd is an Indian public company founded in 1963 with 10,066 employees, providing IT services and solutions.

          DANAHER CORPORATION

          Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees, operating as a diversified conglomerate.

          KONINKLIJKE PHILIPS N.V.

          Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees, operating as a global diversified technology corporation.

          SECTRA AB

          Sectra AB is a Swedish public company founded in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.

          HAMAMATSU PHOTONICS K.K.

          Hamamatsu Photonics K.K. is a Japanese public company founded in 1953 with 6,601 employees, manufacturing photonic products and systems.

          QUANTERIX CORPORATION

          Quanterix Corporation is a public company founded in 2007 in the United States with 450 employees, specializing in biotech instrumentation.

          FUJIFILM HOLDINGS CORPORATION

          Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, operating across imaging, healthcare, and materials sectors.

          HOLOGIC, INC.

          Hologic, Inc. is a private company founded in 1985 in the United States with 7,070 employees, specializing in medical diagnostics and imaging.

          AIFORIA

          Aiforia is a Finnish public company founded in 2013 with 76 employees, specializing in artificial intelligence solutions.

          North America vs. other regions

          HowNorth America compares to the other 3 regional blocs covered in this market.

          Europe
          ~USD 376.8 Million · 11.5% wtd CAGR ·
          Asia Pacific
          ~USD 273 Million · 12.7% wtd CAGR ·
          Latin America
          ~USD 57.1 Million · 9.9% wtd CAGR ·
          Middle East & Africa
          ~USD 34 Million · 9.4% wtd CAGR ·

          Countries within North America - compare and drill down

          Country2025 size (native)
          USUSD 980.4 Million
          CanadaUSD 122.7 Million

          Country market size visualization

          US
          USD 980.4 Million
          Canada
          USD 122.7 Million

          Reasons to Buy this Report

          • Market Size & Growth Data : Access precise valuation of North America's digital pathology market at $280M (2026) and $463.9M (2031), with detailed country-level breakdowns for US and Canada to inform investment and expansion strategies.
          • Competitive Landscape Analysis : Understand the vendor ecosystem, market consolidation trends, and competitive positioning of leading digital pathology solution providers operating across North American healthcare systems and diagnostic laboratories.
          • Regulatory & Reimbursement Insights : Gain clarity on FDA approval pathways, Health Canada regulations, and insurance reimbursement models that directly impact adoption rates and revenue opportunities for digital pathology vendors in North America.
          • Technology Adoption Trends : Identify emerging technologies such as AI-powered image analysis, cloud-based platforms, and telepathology integration that are driving North American healthcare providers' digital transformation initiatives.
          • Strategic Growth Opportunities : Discover high-potential market segments, underserved regions, and partnership opportunities within North America's digital pathology ecosystem to accelerate business growth and market penetration.

          Frequently asked questions

          What is the current size of North America's digital pathology market?

          North America's digital pathology market is valued at $280.0 million in 2026.

          What is the projected market size for North America by 2031?

          North America's digital pathology market is forecast to reach $463.9 million by 2031.

          What is the CAGR for North America's digital pathology market?

          North America's digital pathology market is expected to grow at a compound annual growth rate of 10.6% from 2026 to 2031.

          What factors are driving growth in North America's digital pathology market?

          North America's market growth is driven by increased adoption of AI-powered diagnostics, demand for remote pathology services, laboratory automation, and favorable reimbursement policies.

          Why is North America a key region for digital pathology innovation?

          North America's mature healthcare infrastructure, strong regulatory frameworks, high healthcare spending, and early technology adoption make it a leading region for digital pathology advancement.

          RESEARCH METHODOLOGY

          This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

          Secondary Research

          This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital pathology market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.

          Primary Research

          In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital pathology market. Primary sources from the demand side included personnel from pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, and academic & research institutes.

          Digital Pathology Market Size, and Share

          *Others include sales managers, marketing managers, and product managers.

          Note: Tiers are defined based on a company’s total revenue as of 2025: Tier 1 = > USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

          To know about the assumptions considered for the study, download the pdf brochure

          Market Size Estimation

          The total size of the digital pathology market was determined through data triangulation using the two approaches described below. After completing each approach, a weighted average was calculated based on the level of assumptions used in each approach.

          Digital Pathology Market Top Down and Bottom Up Approach

          Data Triangulation

          The size of the digital pathology market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as follows: -

          • Revenues for individual companies were gathered from public sources and databases.
          • Shares of leading players in the digital pathology market were gathered from secondary sources to the extent available. In certain cases, shares of digital pathology businesses have been determined through a detailed analysis of various parameters, including product portfolios, market positioning, selling prices, and geographic reach & strength. 
          • Individual shares or revenue estimates were validated through interviews with experts.
          • The total revenue in the digital pathology market was determined by extrapolating the market share data of major companies.

          Market Definition

          Digital pathology is an image-based information environment for managing and interpreting information generated from digitized glass slides. The process involves converting glass slides to digital pathology slides using digital pathology scanning solutions. A digital image is then generated, enabling high-resolution slide viewing.

          Key Stakeholders

          • Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Ambulatory Centers, and Outpatient Clinics)
          • Digital Pathology Organizations
          • Senior Management
          • Finance/Procurement Department
          • R&D Department
          • Healthcare Data Aggregators
          • Venture Capitalists
          • Government Agencies
          • Healthcare Startups, Consultants, and Regulators
          • Academic Medical Institutes

          Report Objectives

          • To define, describe, and forecast the digital pathology market based on product, type, technology, application, therapeutic area, end user, and region
          • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
          • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall digital pathology market
          • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
          • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa.
          • To profile the key players and analyze their market shares and core competencies2
          • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital pathology market
          • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

          Available customizations:

          With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

          Company Information

          • Detailed analysis and profiling of additional market players (up to 5)

          Geographic Analysis

          • Further breakdown of the Rest of Asia Pacific digital pathology market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
          • Further breakdown of the Rest of Europe digital pathology market into Russia, Austria, Finland, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries

           

          Get the Full Digital Pathology Market Report

          Full forecast, segment splits, and company analysis for all Digital Pathology Market.

          Download Sample Pages Buy Report

          METHODOLOGY

          Need a Tailored Report?

          Customize this report to your needs

          Get 10% FREE Customization

          Customize This Report
          Fact checked
          Cite this Research
          DMCA.com Protection Status